Evaluation the Effects of Herbal Gargle for Chemoradiotherapy-induced Oral Mucositis of Head & Neck Cancer, a Pilot Study.
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 80
- 试验地点
- 1
- 主要终点
- Change of CTCAE 4.0
研究概览
简要总结
The aim of the study is to evaluate the effects of Herbal gargle on chemoradiotherapy-induced stomatitis in head & neck cancer patients.
详细描述
Head and neck cancer accounts for about 5% of all cancers worldwide with the age-standardized incidence rate (ASIR) of HNC increased by 5.4% per year among males and 3.1% among females in Taiwan. Concurrent chemoradiotherapy (CCRT) is the most common management to treat head and neck cancer. However, CCRT may cause much side effects such as oral mucositis, radiation dermatitis, xerostomia, or infection, which influence food intake, disturb nutritional status and interrupt the course of treatment. Traditional Chinese Medicine (TCM) has been applied to treat cancer side effects for many years. Herbal gargle is composed of TCM herbals used for oral mucositis induced by chemoradiotherapy among head and neck cancer. The aim of the trial is to evaluate the effectiveness of Herbal gargle. The participants divide into two groups, treatment group and control group. The treatment group receive Herbal gargle 150ml and are instructed to hold the gargle in the mouth for 30s and then expectorate it twice a day, 5 days a week for 8 weeks. The control group receive normal saline 150ml for oral mucositis. The subjective questionnaires of EORTC QLQ-C30, EORTC QLQ-H&N35 are assessed twice a week, CTCAE for grading of oral mucositis is assessed once a week, VAS is assessed everyday for 8 weeks. Besides, change of opioid dosage, body weight are also recorded. The CRP is assessed before and every week for 8 weeks and the albumin and bacteria culture are assessed before and post-treatment of 4th week and 8th week. The baseline difference of treatment and control group will be analyzed by using independent t-test and the difference of evaluation scores and blood tests between pre-treatment and post-treatment will be analyzed using multivariate logistic regression analysis. A value of P < 0.05 will be regarded as statistically significant for the above statistical analyses.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
盲法说明
The color of Herbal gargle is yellowish while normal saline is transparent. Therefore, the study belongs to open label trial.
入排标准
- 年龄范围
- 20 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Willing to join the trial project and sign the informed consent form.
- •Age more than 20 years-old.
- •Pathology proved to be head and neck cancers.
- •Head and neck cancer patients under radiotherapy or concurrent chemoradiotherapy.
- •Expected life expectancy more than 3 months.
- •Subjects with clear consciousness and can be assessed cooperatively.
- •Subjects are suitable to use Herbal gargle evaluated by Traditional Chinese medicine physicians.
排除标准
- •Subjects can not sing the informed consent form.
- •Systemic infection.
- •Heart, liver and kidney insufficiency
- •Allergy history of Traditional Chinese medicine
- •Unclear conscious to use Herbal gargle.
研究组 & 干预措施
Treatment group
The treatment group receive Herbal gargle 150ml and are instructed to hold the gargle in the mouth for 30s and then expectorate it twice a day, 5 days a week for 8 weeks.
干预措施: Herbal gargle (Drug)
Control group
The control group receive Normal saline 150ml and are instructed to hold the normal saline in the mouth for 30s and then expectorate it twice a day, 5 days a week for 8 weeks.
干预措施: Normal saline (Other)
结局指标
主要结局
Change of CTCAE 4.0
时间窗: change from baseline and every week for 8 weeks.
CTCAE is used to describe the severity of oral mucositis for patients receiving cancer therapy.
次要结局
- Change of CRP(change from baseline and every week for 8 weeks.)
- Change of opioid use(change from baseline and every week for 8 weeks.)
- Change of EORTC QLQ-H&N35(change from baseline at 4 weeks and 8 weeks post treatment.)
- Change of VAS of pain of oral mucositis(change from baseline and everyday for 8 weeks.)
- Change of body weight(change from baseline and every week for 8 weeks.)
- Change of albumin(change from baseline at 4 weeks and 8 weeks post treatment.)
- Change of common aerobic culture(change from baseline and every week for 8 weeks.)
- Change of EORTC QLQ-C30(change from baseline at 4 weeks and 8 weeks post treatment.)
